Sign in
4

Changes in Ownership

LENZ Therapeutics, Inc. Filed Acc 0000899243-21-027012

Director acquired 8,126 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
KARSEN PERRY A Director 2021-06-29 Conversion +8,126 164,034 D
Derivatives
KARSEN PERRY A Director 2021-01-13 Grant or award · Stock Option (right to buy) +74,794 74,794 D
KARSEN PERRY A Director 2021-03-11 Grant or award · Series B Preferred Stock +19,763 $5.06 $100,001 19,763 D
KARSEN PERRY A Director 2021-03-17 Grant or award · Stock Option (right to buy) +18,698 18,698 D
KARSEN PERRY A Director 2021-06-29 Conversion · Series B Preferred Stock −19,763 0 D
Loading xslF345X03/doc4.xml…